Nick Leschly
2017 - bluebird bio
In 2017, Nick Leschly earned a total compensation of $8.8M as Chief Executive Officer at bluebird bio, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $431,200 |
|---|---|
| Option Awards | $5,683,090 |
| Salary | $560,000 |
| Stock Awards | $2,079,000 |
| Other | $9,000 |
| Total | $8,762,290 |
Leschly received $5.7M in option awards, accounting for 65% of the total pay in 2017.
Leschly also received $431.2K in non-equity incentive plan, $560K in salary, $2.1M in stock awards and $9K in other compensation.
Rankings
In 2017, Nick Leschly's compensation ranked 808th out of 14,666 executives tracked by ExecPay. In other words, Leschly earned more than 94.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 808 out of 14,666 | 95th |
Division Manufacturing | 268 out of 5,772 | 95th |
Major group Chemicals And Allied Products | 65 out of 2,075 | 97th |
Industry group Drugs | 45 out of 1,731 | 97th |
Industry Biological Products, Except Diagnostic Substances | 7 out of 313 | 98th |
Source: SEC filing on April 27, 2018.
Leschly's colleagues
We found four more compensation records of executives who worked with Nick Leschly at bluebird bio in 2017.
News
2seventy bio CEO Nick Leschly's 2023 pay jumps 49% to $9.1M
April 25, 2024
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
2seventy bio CEO Nick Leschly's 2021 pay rises 1% to $6.3M
April 26, 2022
bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
April 27, 2020
bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
April 23, 2019